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in 6 patients, terminating in death in 4 of them. In the second
unit, 4 patients only had neuromuscular disorders of varied
causes: polyneuritis, steroid-induced myopathy. Bone changes
were moderate and of the common renal osteodystrophic type.
Electroencephalograms (EEG) showed no alterations such as
those in the first unit. No case of dialysis encephalopathy was
observed. Aluminum concentration was much higher in water,
dialysis fluid, and blood in the former unit than in the later. These
observations confirm the well-known relationship between
osteomalacic osteodystrophy and dialysis encephalopathy. They
also point out that serial EEG can be useful in detecting changes
which precede clinical signs of encephalopathy.
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DNA/anti-DNA complexes in systemic lupus erythematosus and
idiopathic nephritis. D. Adu, D. Gwyn Williams, and J. Dobson.
Renal Unit, Guy's Hospital, London, England. Although there is
considerable evidence that circulating antigen-antibody com-
plexes are important in the tissue damage of systemic lupus cry-
thematosus (SLE), the composition of these complexes, and in
particular the role of DNA and anti-DNA antibodies in their
formation, remains uncertain and controversial. We have
studied cryoglobulins from 38 patients with SLE and nephritis;
only 3 patients were not receiving immunosuppressive drugs
at the time of study. Resolubilized cryoglobulins from these
patients were examined for DNA using the ethidium bro-
mide fluorescence technique. Dissociation of these cryoglobulins
into their constituent immunoglobulins was performed by su-
crose density ultracentrifugation in an acid buffer. Antibody ac-
tivity against double-stranded (ds) DNA was examined using the
Farr assay with '251-dsDNA as ligand, and single-stranded (ss)
DNA antibodies were detected by means of a solid-phase en-
zyme-linked immunoassay using heat-denatured DNA as anti-
gen. DNA was detected in 23 of 33 SLE cryoglobulins. Anti-
bodies to DNA were found in 11 out of 17 cryoglobulin IgG frac-
tions. Antibody activity was directed against dsDNA in 7 cases
and against ssDNA in 6 cases. Four of 8 cryoglobulin 1gM frac-
tions also showed anti-dsDNA activity. Two out of 16 cryoglobu-
tin IgG fractions showed anti-IgG activity as did 4 out of 8 cryo-
globulin 1gM fractions. These studies indicate that the circulating
antigen-antibody complexes in SLE consist in part of IgG and
1gM antibodies to DNA and to IgG. As controls for the above
studies, we examined cryoglobulins from patients with idiopathic
mesangiocapillary (6 patients) and membranous glornerulone-
phritis (9 patients). DNA was detectable in these cryoglobulins
too, but to date we have not been able to demonstrate any associ-
ated anti-DNA activity in the same cryoglobulins.
The relevance of immune complex assays to the management of
systemic lupus erythematosus. S. A. Cairns, R. A. London, N. P.
Mallick, F. S. Goldby, and R. S. H. Pumphrey. Departments of
Renal Medicine and Immunology, Manchester Royal Infirmary,
England. Sixteen patients with systemic lupus erythematosus, 14
with renal involvement, were followed for up to 2 years. All dem-
onstrated disease activity during this time. One hundred forty-
one sequential serum samples were examined for immune com-
plexes by three techniques. These serum samples were assayed
using the inhibition of latex IgG aggregation by rabbit 1gM anti-
IgG(LG), 119 by the same assay using human Clq instead of 1gM
(La), and 81 by a solid phase Clq binding anti-IgG assay (Se).
Sixty-four percent gave positive results with the LG assay, 52%
with the L assay, and 55% by the S assay; 77% of the 141 sera
were positive in at least one assay. Although the L and L assay
results (r = 0.625, P = <0.001) and those for LG and Sc (r =
0.426, P = <0.001) showed a positive correlation, the L and S
results did not. Immune complex levels were correlated with
serum anti-dsDNA antibody, CH50, C3, Clq, C4, and factor B
levels, and with disease activity assessed by three different scor-
ing methods. Eleven patients received 16 "pulses" of high-dose
intravenous methylprednisolone therapy. We found no change in
total immune complex levels following 11 such pulses. Using
sepharose 6B gel column chromatography, we studied the size of
complexes present in 10 sera from 6 patients, in some cases fol-
lowing methylprednisolone therapy. Complexes of size 600,000
to 900,000 daltons seem to be associated with renal involvement.
The level of these complexes falls after steroid "pulsing," and
higher molecular-weight complexes appear.
Role of the renin-angiotensin-aldosterone system in the nephrotic
syndrome (NS). E. J. Dorhout Mees, J. C. Roos, and P. Boer.
Department of Nephrology & Hypertension, University Hospi-
tal, Utrecht, The Netherlands. We previously reported a series
of adult patients with minimal lesion NS who showed no evi-
dence of activation of the renin system, which would have been
expected if the traditional "hypovolaemic" explanation of ede-
ma formation in this condition were valid. Lowered levels of re-
nm substrate (RS) in the nephrotic syndrome have been reported
as a partial explanation for the relatively low PRA levels. We
report the results of systematic RS determination in patients with
the NS. In normal men and women (without contraceptives), RS
was 870 95 and 725 80, respectively, and did not change
after salt restriction. In 26 patients with the NS of variable etiol-
ogy, decreased RS values were found in 2, and elevated values in
10. There was no correlation with PRA levels or the amount of
protein loss. In 4 out of 10 patients with minimal lesions, RS rose
after prednisone-induced remission, but this may have been re-
lated to a direct steroid-effect. One patient with extreme protein
loss, hypovolemia, and very high PRA is reported in more detail,
as sequential studies during development as well as steroid-in-
duced remission of the edema could be performed. The PRS was
elevated and did not change during edema formation. In contrast
to the group of patients mentioned in the introduction, her filtra-
tion fraction was elevated (0.49) during the nephrotic phase.
It is concluded that renin substrate is not decreased in the NS.
Our findings support the concept that the majority of adult pa-
tients with the nephrotic syndrome do not have hypovolemia and
that this is a sufficient explanation for their normal plasma renin
and aldosterone levels.
Urethral syndrome: A possible explanation? R. Maskell, L. Pead,
and J. Allen. Public Health Laboratory, St. Mary's General
Hospital, Portsmouth, England. About 50% of patients who
complain of dysuria and frequency do not have significant bacte-
riuria when conventional culture methods are used, and the diag-
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nosis of urethral syndrome has been applied to them. We have
incubated urine specimens in an atmosphere containing 7% CO2
for up to 48 hours. Gram-positive organisms not hitherto recog-
nized as urinary pathogens were isolated in pure culture from
men and women with urinary symptoms. Sixty-five percent of
the specimens from which these organisms were isolated showed
pyuria. Appropriate treatment resulted in the disappearance of
symptoms, cells, and organisms in 93% of the patients. Fifty-five
percent of the women were known to have had other episodes of
urinary symptoms, either with aerobic bacteriuria or with pyuria,
but sterile or inconclusive cultures on overnight incubation in
air. We suggest that these organisms may account for episodes of
urinary symptoms hitherto diagnosed as "urethral syndrome,"
and that prospective clinical/bacteriologic studies are now re-
quired.
Hypertension in parenchymatous renal disease. M. I. Mitchell, S.
F. Wong, V. Robson, andR. Wilkinson. Department of Nephrol-
ogy, Freeman Hospital, Newcastle upon Tyne, England. The
mechanism of the hypertension which occurs in approximately
half of patients with renal disease without severe impairment of
function is not known. Kleinknecht and Maxwell (1970) found
that blood pressure was related to PRA, but not to plasma vol-
ume, exchangeable sodium (NaE) or total body water in these
patients. Beretta-Piccoli et al (1976) on the other hand found
blood pressure to be related to NaE but not to renin. We have
studied 100 patients with renal disease not requiring dialysis and
43 control subjects of similar age. Comparisons have been made
after division of subjects into three groups, 51 patients who were
hypertensive (diastolic pressure> 100 mm Hg), 49 normotensive
patients with renal disease, and the 43 normotensive control sub-
jects. There was a significant although not close correlation be-
tween mean arterial pressure (MAP) and log PRA (r = +0.22,P
<0.02). However, mean PRA levels were lower in both hyper-
tensive and normotensive renal patients than in the control
group. This suppression of PRA in the renal patients was not
explained by age differences nor by salt retention. However, we
found that log PRA was inversely related to plasma K (r
—0.33, P < 0.001), and this may be the reason for the lowered
renin levels. There were no differences in exchangeable sodium
between the three groups studied, and in the renal patients no
relationship was found between blood pressure and exchange-
able sodium. Plasma aldosterone levels did not differ in the three
groups and were not related to blood pressure. These results sug-
gest that hypersecretion of renin may be an important factor in
the pathogenesis of hypertension in early renal disease. The find-
ing of reduced mean levels of PRA in renal patients does not
invalidate this conclusion because there may be altered sensitivi-
ty to renin in these patients.
Circulating immune complexes in antiglomerular basement mem-
brane disease. B. A. Pussell, C. M. Lockwood, A. J. Rees, A. J.
Pinching, and D. K. Peters, Royal Postgraduate Medical
School, Ham mersmith Hospital, London. Two complement-de-
pendent immune complex assays—the Clq binding assay (ClqB)
and a conglutinin-binding assay (KgB)—were used to monitor 25
patients undergoing treatment of antiglomerular basement mem-
brane (aGBM) disease. Persistently abnormal levels of circulat-
ing immune complexes (CIC) developed late in the course of the
disease in 6 patients (CIqB, 5 patients; KgB, 2 patients). Sequen-
tial studies on these 6 patients showed that of 4 who retained
some renal function 3 developed a rising serum creatinine associ-
ated with the appearance of CIC, and in one the renal function
remained stable. The remaining two patients had end-stage renal
failure and were being treated by dialysis. The level of circulating
sGBM antibody was negative or falling in all 6 patients at the
time CIC appeared (see table).
Renal function
Anti-GBM% (Sreat,
Patient ClqB KgB (normal <12) pmoleslliter)
Although we have previously seen deteriorating renal function in
aGBM disease associated with infection, in only one of these 6
patients could the presence of CIC be attributed to infection, and
this patient developed a relapse (renal and pulmonary). The find-
ing of CIC and worsening renal function in this group of patients
suggest that one form of immunologic injury (immune complex
mediated) may be superimposed upon another (antibody mediat-
ed) and can contribute to organ damage.
1 + — 33—* 21
2 + — 15—<10
3 + — 25—*<10
4 + — <10
5 + — <10
6 — + <10
Hemodialysis
625 — 780
260 — 350
Hemodialysis
Stable 160
480 —* 990
